Case Number:

IPR2019-00554

Case Type:

IPR

Status:

Final Written Decision

Petitioner:

Moderna Therapeutics, Inc.

Patent Owner:

Arbutus Biopharma Corporation

Patent Number:

8,058,069

Tech Center:

1600

1. Filed: January 09, 2019 00:00

   Coverage

   1. July 23, 2020

      Moderna Can't Invalidate Drug-Delivery Composition Patent

      The Patent Trial and Appeal Board ruled Thursday that Moderna Therapeutics Inc. failed to invalidate claims in Arbutus Biopharma Corp.'s patent covering a drug-delivery composition as obvious or anticipated based on overlapping composition ranges, finding that prior art does not explicitly disclose such ranges.

   2 other articles on this case. View all »

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login